Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: April 16, 2025
Abstract
Copy
number
variants
(CNVs)
are
an
important
class
of
genomic
variation
known
to
be
for
human
physiology
and
diseases.
Here
we
present
genome-wide
metabolomic
signatures
CNVs
in
two
Finnish
cohorts—The
Northern
Finland
Birth
Cohort
1966
(NFBC
1966)
NFBC
1986.
We
have
analysed
reported
over
9,300
individuals
characterised
their
dosage
effect
(CNV-metabolomic
QTL)
on
228
plasma
lipoproteins
metabolites.
reference
(normal
physiology)
up
~
2.6
million
COVID-19
GWAS
results
from
the
National
Institutes
Health
(NIH)
GRASP
database,
including
outcomes
related
death,
severity,
hospitalisation.
Furthermore,
by
analysing
exemplar
genes
severity
namely
LZTFL1
OAS1,
here
additional
candidate
biology,
(1)
NFIX,
a
gene
viral
(adenovirus)
replication
hematopoietic
stem
cells
(2)
ACSL1,
sepsis
bacterial
inflammation.
Based
our
current
literature
hypothesise
that
charge
imbalance
across
cellular
membrane
between
cations
(Fe
2+
,
Mg
etc.)
anions
(e.g.
ROS,
hydroxide
ion
Fenton
reactions,
superoxide
etc.),
iron
trafficking
within
different
cell
types
e.g.,
macrophages
(3)
systemic
oxidative
stress
response
lipid
peroxidation
mediated
inflammation),
together
could
relevance
severe
cases.
To
conclude,
unique
atlas
univariate
multivariate
(~
7.2
signatures)
with
deep
annotations
various
multi-omics
data
sets
provide
knowledge
base
metabolism
Nature Reviews Microbiology,
Journal Year:
2023,
Volume and Issue:
unknown
Published: Jan. 18, 2023
In
late
2020,
after
circulating
for
almost
a
year
in
the
human
population,
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
exhibited
major
step
change
its
adaptation
to
humans.
These
highly
mutated
forms
of
SARS-CoV-2
had
enhanced
rates
transmission
relative
previous
variants
and
were
termed
'variants
concern'
(VOCs).
Designated
Alpha,
Beta,
Gamma,
Delta
Omicron,
VOCs
emerged
independently
from
one
another,
turn
each
rapidly
became
dominant,
regionally
or
globally,
outcompeting
variants.
The
success
VOC
previously
dominant
variant
was
enabled
by
altered
intrinsic
functional
properties
virus
and,
various
degrees,
changes
antigenicity
conferring
ability
evade
primed
immune
response.
increased
fitness
associated
with
is
result
complex
interplay
biology
context
changing
immunity
due
both
vaccination
prior
infection.
this
Review,
we
summarize
literature
on
transmissibility
variants,
role
mutations
at
furin
spike
cleavage
site
non-spike
proteins,
potential
importance
recombination
success,
evolution
T
cells,
innate
population
immunity.
shows
complicated
relationship
among
antigenicity,
virulence,
which
has
unpredictable
implications
future
trajectory
disease
burden
COVID-19.
Viruses,
Journal Year:
2023,
Volume and Issue:
15(1), P. 175 - 175
Published: Jan. 7, 2023
The
clinical
course
and
outcome
of
COVID-19
are
highly
variable,
ranging
from
asymptomatic
infections
to
severe
disease
death.
Understanding
the
risk
factors
is
relevant
both
in
setting
at
epidemiological
level.
Here,
we
provide
an
overview
host,
viral
environmental
that
have
been
shown
or
(in
some
cases)
hypothesized
be
associated
with
outcomes.
considered
detail
include
age
frailty,
genetic
polymorphisms,
biological
sex
(and
pregnancy),
co-
superinfections,
non-communicable
comorbidities,
immunological
history,
microbiota,
lifestyle
patient;
variation
infecting
dose;
socioeconomic
factors;
air
pollution.
For
each
category,
compile
(sometimes
conflicting)
evidence
for
association
factor
outcomes
(including
strength
effect)
outline
possible
action
mechanisms.
We
also
discuss
complex
interactions
between
various
factors.
Science,
Journal Year:
2023,
Volume and Issue:
380(6644), P. 485 - 490
Published: May 4, 2023
Autoimmune
diseases
display
a
high
degree
of
comorbidity
within
individuals
and
families,
suggesting
shared
risk
factors.
Over
the
past
15
years,
genome-wide
association
studies
have
established
polygenic
basis
these
common
conditions
revealed
widespread
sharing
genetic
effects,
indicative
immunopathology.
Despite
ongoing
challenges
in
determining
precise
genes
molecular
consequences
variants,
functional
experiments
integration
with
multimodal
genomic
data
are
providing
valuable
insights
into
key
immune
cells
pathways
driving
diseases,
potential
therapeutic
implications.
Moreover,
ancient
populations
shedding
light
on
contribution
pathogen-driven
selection
pressures
to
increased
prevalence
autoimmune
disease.
This
Review
summarizes
current
understanding
disease
genetics,
including
mechanisms,
evolutionary
origins.
Genome Medicine,
Journal Year:
2022,
Volume and Issue:
14(1)
Published: Aug. 19, 2022
Since
the
start
of
coronavirus
disease
2019
(COVID-19)
pandemic,
important
insights
have
been
gained
into
virus
biology
and
host
factors
that
modulate
human
immune
response
against
severe
acute
respiratory
syndrome
2
(SARS-CoV-2).
COVID-19
displays
a
highly
variable
clinical
picture
ranges
from
asymptomatic
to
lethal
pneumonia.
Apart
well-established
general
risk
such
as
advanced
age,
male
sex
chronic
comorbidities,
differences
in
genetics
shown
influence
individual
predisposition
develop
manifestations
COVID-19.
These
range
common
susceptibility
loci
rare
genetic
variants
with
strongly
predisposing
effects,
or
proven
pathogenic
lead
known
novel
inborn
errors
immunity
(IEI),
which
constitute
growing
group
heterogeneous
Mendelian
disorders
increased
infectious
disease,
auto-inflammation,
auto-immunity,
allergy
malignancies.
The
current
findings
point
towards
convergence
impact
interferon
signalling
pathways
patients
critical
Monogenic
IFN-I
an
expected
prevalence
between
1
5%
young,
previously
healthy
individuals
(<60
years
age)
identification
these
IEI
X-linked
TLR7
deficiency
indicates
possibility
for
targeted
screening
personalized
management.
This
review
aims
provide
overview
our
understanding
predispose
focuses
on
genes
their
potential
implications.
Infection Genetics and Evolution,
Journal Year:
2023,
Volume and Issue:
110, P. 105426 - 105426
Published: March 17, 2023
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
is
the
etiologic
agent
of
disease
2019
(COVID-19)
pandemic.
Clinical
manifestations
range
from
an
asymptomatic
condition
to
life-threatening
events
and
death,
with
more
severe
courses
being
associated
age,
male
sex,
comorbidities.
Besides
these
risk
factors,
intrinsic
characteristics
virus
as
well
genetic
factors
host
are
expected
account
for
COVID-19
clinical
heterogeneity.
Genetic
studies
have
long
been
recognized
fundamental
identify
biological
mechanisms
underlying
congenital
diseases,
pinpoint
genes/proteins
responsible
susceptibility
different
inherited
conditions,
highlight
targets
therapeutic
relevance,
suggest
drug
repurposing,
even
clarify
causal
relationships
that
make
modifiable
some
environmental
factors.
Though
usually
take
time
be
concluded
and,
above
all,
translate
their
discoveries
patients'
bedside,
scientific
community
moved
really
fast
deliver
signals
phenotypes.
In
this
Review,
besides
a
concise
description
symptomatology
SARS-CoV-2
mechanism
infection,
we
aimed
recapitulate
current
literature
in
terms
specifically
associate
increased
severity
disease.
Journal of Cellular and Molecular Medicine,
Journal Year:
2024,
Volume and Issue:
28(4)
Published: Feb. 1, 2024
Abstract
Complement
inhibition
has
shown
promise
in
various
disorders,
including
COVID‐19.
A
prediction
tool
complement
genetic
variants
is
vital.
This
study
aims
to
identify
crucial
complement‐related
and
determine
an
optimal
pattern
for
accurate
disease
outcome
prediction.
Genetic
data
from
204
COVID‐19
patients
hospitalized
between
April
2020
2021
at
three
referral
centres
were
analysed
using
artificial
intelligence‐based
algorithm
predict
(ICU
vs.
non‐ICU
admission).
recently
introduced
alpha‐index
identified
the
30
most
predictive
variants.
DERGA
algorithm,
which
employs
multiple
classification
algorithms,
determined
of
these
key
variants,
resulting
97%
accuracy
predicting
outcome.
Individual
variations
ranged
40
161
per
patient,
with
977
total
detected.
demonstrates
utility
ranking
a
substantial
number
approach
enables
implementation
well‐established
algorithms
that
effectively
relevance
outcomes
high
accuracy.
Communications Biology,
Journal Year:
2024,
Volume and Issue:
7(1)
Published: Jan. 24, 2024
Abstract
Type
2
diabetes
(T2D)
is
known
as
one
of
the
important
risk
factors
for
severity
and
mortality
COVID-19.
Here,
we
evaluate
impact
T2D
its
genetic
susceptibility
on
COVID-19,
using
459,119
individuals
in
UK
Biobank.
Utilizing
polygenic
scores
(PRS)
T2D,
identified
a
significant
association
between
or
PRS,
COVID-19
severity.
We
further
discovered
efficacy
vaccination
pivotal
role
T2D-related
genetics
pathogenesis
severe
Moreover,
found
that
with
those
high
PRS
group
had
significantly
increased
rate.
also
observed
rate
SARS-CoV-2-infected
patients
was
approximately
to
7
times
higher
than
not
infected,
depending
time
infection.
These
findings
emphasize
potential
estimating